Menu
POTENTIAL DEAL DETAILS
| Stock | Singular Genomics Systems, Inc. | Symbol | OMIC |
| Date Announced | 09/12/2024 | Source | Press Release |
| Type | Unsolicited Bid | Acquiring Company/Person | Deerfield Management Company, L.P., Concentra Biosciences and Tang Capital Partners |
Singular Genomics (OMIC) announced that it has received a non-binding proposal from Deerfield and certain affiliated funds, to acquire all of the company’s outstanding shares of common stock that are not already owned by Deerfield for $10.00 per share in cash.
Deerfield, an existing stockholder of the Company, indicated in its letter that it intends to invite other major stockholders and existing management to roll over their shares of common stock into the new company.
Singular Genomics Systems, Inc. Investor Relations
Deerfield Management Company, L.P. Investor Relations
Update(s):
September 19, 2024: Concentra Biosciences, LLC and Tang Capital Partners, which owns about 14.9% of Singular Genomics (OMIC), offered to buy the remaining outstanding shares of the company for $12.00 per share in cash. Tang also gave an alternative offer to the stockholders to receive a CVR (contingent value right) rather than the per share cash value.
Disclaimer: Our intent with this section of the website is to present potential deals that appear to be in the pipeline. These potential deals are ones where i) the company has indicated that it is "seeking strategic alternatives", ii) there has been an unsolicited bid for a company as mentioned in a press release by the company or iii) news about the deal has been published by a leading news organization like The Wall Street Journal, The New York Times, Bloomberg, Financial Times, The Washington Post, Reuters and The Associated Press. As best as possible we will try to avoid baseless rumors. There is a high probability that many of these potential deals may not materialize and if they do, the terms of the deal may be different from what was initially reported. Please do your own due diligence before buying or selling any securities mentioned on this website. We do not warrant the completeness or accuracy of the content or data provided.